Careers in Discovery

Jon Green left school with no qualifications and little idea of what his future held - now, he's the VP & Site General Manager of AstraZeneca's Granta Park site and Chairman of the biotech networking body One Nucleus. 

Looking back on an illustrious career in drug discovery, he shares with us what he's learnt from his unconventional path, including the key role that passion for what you do plays, the real life impact of working in drug discovery and development and why "walking the floor" is his modus operandi.

Hear Jon's fascinating story on this episode of Careers in Discovery.

Benedict Cross, Head of Functional Genomic Screening at Horizon Discovery, joins us this time.

Join us as we discuss, among many other things:

❇ Functional Genomics and the impact of CRISPR on drug discovery

❇ Why knowing what NOT to do can be the most important thing you learn

❇ How the outcry over GMO kick-started Benedict's career in science

❇ Using your network

Professor Tom Moody, VP of Technology Development & Commercialisation at Almac Group joins us this week, and provides a fascinating insight into a career at the cutting edge of chemistry.

We discussed:

Doing the impossible as part of your job

How technology is changing the role of the scientist

The importance of continued learning

The differences between academia and industry, and what you need to make the transition

This week we're joined by Matt Higgins, CEO of Blue Ridge Bioinformatics, a specialist bioinformatics service provider to Pharma & Biotech companies.

We covered a lot of ground, including:

💡 The impact of bioinformatics in drug discovery

💡 Catching the entrepreneurship bug

💡 Stepping out of your comfort zone

💡 The challenges of proving your credibility as a young founder

"Things that excite me a lot and scare me a little are definitely worth doing."

We're joined in this episode by Zuzanna Brzosko, CEO of Sixfold Bioscience, an exciting early stage company developing novel drug delivery technologies for Cell & Gene Therapy.

Zuzanna shares with us what she's learned in her first year as a CEO, the importance of diversity of background but convergence in direction when building a team, and how crucial it is to take action.

We're joined by Ted Fjallman, CEO of Prokarium, a vaccines and immunotherapy company with some fascinating targets. 

Ted shares with us his journey from young LEGO builder to the European Space Agency and eventually drug development, the importance of following your passion, his view on the unspoken war in microbial resistance and how science will survive AI.